POMC and Parkinson disease: After receiving 8 weeks of MA treatment, PD patients showed significant improvement in HAMA, UPDRS, and PDQ-39 scores, as well as downregulation of serum levels of adrenocorticotropic hormone (ACTH), thereby improving anxiety symptoms (Fan et al., 2022).